johnson & johnson

A federal health panel has recommended that J&J recipients receive a booster shot.
A panel of health advisers said people who received Johnson & Johnson's single-shot vaccine would benefit from a booster dose.
J&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.
A booster dose of the Johnson & Johnson vaccine produced an increased antibody response in adults from age 18 to 55, newly released data shows.
Here's what the latest news on the additional doses means for you.
Consumers are being urged to stop using them immediately.
The FDA added a warning on the J&J shot after some people developed a rare disorder. Here's why you shouldn't panic.
Regulators said the risk of getting Guillain-Barré syndrome from the Johnson & Johnson COVID-19 vaccine was low.
Here's what experts think about mixing vaccines and if there's a need for an extra dose with the delta coronavirus variant.
The company has agreed to permanently stop selling opioids across the country, not just New York state.